Cargando…
COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series
BACKGROUND: COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an invasive fungal disease, often affecting previously immunocompetent, mechanically ventilated, intensive care unit (ICU) patients. Incidence rates of 3.8%–33.3% have been reported depending on the geographic area, with h...
Autores principales: | Meijer, Eelco F. J., Dofferhoff, Anton S. M., Hoiting, Oscar, Meis, Jacques F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986084/ https://www.ncbi.nlm.nih.gov/pubmed/33569857 http://dx.doi.org/10.1111/myc.13254 |
Ejemplares similares
-
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report
por: Meijer, Eelco F. J., et al.
Publicado: (2020) -
COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study
por: Iqbal, Ahtesham, et al.
Publicado: (2021) -
Filamentous Fungi in Respiratory Infections. What Lies Beyond Aspergillosis and Mucormycosis?
por: Chowdhary, Anuradha, et al.
Publicado: (2016) -
Surgical treatment of pulmonary aspergillosis: A single center experience
por: Mohapatra, Biswajeet, et al.
Publicado: (2016) -
COVID-19-associated Pulmonary Aspergillosis: A Case Series
por: Sharma, Khushboo, et al.
Publicado: (2022)